DOJ Corporate Fraud Enforcement Directive: Healthcare Compliance Priorities
The U.S. Department of Justice (DOJ) directive Corporate Enforcement in the Fight Against Fraud, released on October 1, 2026, signals intensified enforcement against corporate misconduct involving federal healthcare programs. It supplements existing policies and clarifies the factors most likely to draw scrutiny. That scrutiny will not be limited to large hospitals and health systems. Smaller organizations, including physician practices, clinics, laboratories, pharmacies, and other participants in federally funded programs, should also expect prosecutors’ attention.
This enforcement directive provides a practical roadmap: strong controls, informed oversight, prompt escalation, credible investigations, cooperation, and documented remediation can materially influence the government’s response. Healthcare organizations should use it now to assess whether their compliance programs can detect, investigate, and correct misconduct before it becomes an enforcement matter. Prosecutors are instructed to give “great weight” to charging and resolution factors such as management knowledge or participation; concealment or obstruction; the scheme’s duration and reach; the number and vulnerability of victims; financial losses; and harm to taxpayer-funded programs, public health, or safety. Timely voluntary disclosure, full cooperation, evidence preservation, remediation, and individual accountability may significantly affect the outcome.
The directive reinforces a central principle: prosecutors will judge a compliance program by how it operates, not by what its policies promise. Written procedures carry little weight when leaders ignore warning signs, incentives reward improper billing, audit findings remain unresolved, or the organization cannot demonstrate that concerns were investigated and corrected. Because management knowledge is a key consideration, governance is critical. Boards and senior leaders should receive candid compliance reporting, understand the organization’s highest-risk billing and operational areas, and document decisions made in response to identified problems. Compliance officers need sufficient authority, independence, access to data, and resources to test whether controls are effective.
Tips for Compliance Officers
- Conduct a Compliance Risk Assessment. Map the directive’s priority areas to the organization’s services, revenue streams, vendors, government relationships, and geographic footprint.
- Ensure Effective Management and Board Oversight. Confirm that significant allegations, audit findings, overpayments, and control failures are promptly and directly elevated to senior leadership and the board. Document the issues reported, decisions made, and actions taken.
- Review Incentives and Controls. Examine compensation arrangements, coding practices, sales and marketing activities, third-party relationships, and performance metrics for pressures that could encourage misconduct.
- Strengthen Investigation Readiness. Establish protocols for conducting investigations, preserving evidence, coordinating with legal counsel, and escalating matters that may require disclosure.
- Verify Remediation. Track corrective actions through completion and validate their effectiveness in preventing recurrence.
- Reassess Reporting Channels. Ensure employees and contractors can report concerns without fear of retaliation and that credible allegations receive timely, independent review. Analyze hotline data for patterns, recurring issues, or anomalies.
